Ombretta Turriziani

Pubblicazioni

Titolo Pubblicato in Anno
Increased expression of IL-32 correlates with IFN-γ, Th1 and Tc1 in virologically suppressed HIV-1-infected patients CYTOKINE 2019
Copy-years viremia and risk of virological failure in long-term-treated HIV patients JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 2019
Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy SEXUALLY TRANSMITTED INFECTIONS 2019
Comparative analysis of 2 commercial molecular tests for the detection of gastroenteric viruses on stool samples DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE 2019
Activation of latent HIV-1 T cell reservoirs with a combination of innate immune and epigenetic regulators JOURNAL OF VIROLOGY 2019
Quantification of HIV-DNA and residual viremia in patients starting ART by droplet digital PCR: Their dynamic decay and correlations with immunological parameters and virological success JOURNAL OF CLINICAL VIROLOGY 2019
Antiviral activity of fecal water samples from HIV-1 infected subjects treated with a specific probiotic formulation CURRENT HIV RESEARCH 2019
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients CLINICAL MICROBIOLOGY AND INFECTION 2019
Tumor-Targeting Anti-CD20 Antibodies Mediate In Vitro Expansion of Memory Natural Killer Cells: Impact of CD16 Affinity Ligation Conditions and In Vivo Priming FRONTIERS IN IMMUNOLOGY 2018
Impact of the M184V resistance mutation on virological efficacy and durability of lamivudine-based dual antiretroviral regimens as maintenance therapy in individuals with suppressed HIV-1 RNA: A cohort study OPEN FORUM INFECTIOUS DISEASES 2018
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 HIV MEDICINE 2018
Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patient HEMATOLOGICAL ONCOLOGY 2018
Increased SAMHD1 transcript expression correlates with interferon-related genes in HIV-1-infected patients MEDICAL MICROBIOLOGY AND IMMUNOLOGY 2018
Sa1854 - Oral Bacteriotherapy Improves Gut Inflammation and Reduces Fecal Infectivity of HIV Subjects GASTROENTEROLOGY 2018
TREATED HIV-1 PATIENTS WITH DIFFERENT LEVELS OF VIRAL SUPPRESSION: CHANGES IN MICRORNA EXPRESSION PROFILES abstract book Congresso SIV-ISV 2018
HIV-1 DIVERSITY AND ANTIRETROVIRAL RESISTANCE MUTATIONS AMONG TREATMENT NAÏVE PATIENTS FROM 2005-2017: A SINGLE CENTER EXPERIENCE Abstract book SIV congress 2018 2018
Lack of association of Chlamydia pneumoniae with cardiovascular diseases in virologically suppressed HIV patients NEW MICROBIOLOGICA 2017
Consolidation of molecular testing in clinical virology EXPERT REVIEW OF ANTI-INFECTIVE THERAPY 2017
Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns BMC INFECTIOUS DISEASES 2017
Dolutegravir-based regimen maintains virological success in a patient with archived mutations to integrase inhibitors AIDS 2017

ERC

  • LS6_5

Interessi di ricerca

L’infezione da SARS-CoV-2: diagnosi molecolare e gestione del paziente
Resistenza alla terapia antiretrovirale: effetti a lungo termine della terapia antiretrovirale sulla cellula e studio dei meccanismi di resistenza cellulare selezionati dopo trattamento. Ruolo dell’espressione di trasportatori di membrana nella resistenza ai farmaci antiretrovirali. Caratterizzazione in vitro di ceppi di HIV farmacoresistenti. Studio delle varianti di HIV-1 farmacoresistenti in soggetti HIV positivi e analisi del possibile ruolo delle varianti di HIV farmacoresistenti archiviate nei serbatoi cellulari, nel fallimento della terapia antivirale.
Significato clinico della viremia residua in HIV: studi volti ad identificare sia i fattori che contribuiscono alla presenza di viremia residua, sia la relazione esistente tra viremia residua e immunoattivazione/infiammazione cronica.
nel soggetto HIV positivo.
Latenza di HIV: Effetti della terapia antiretrovirale sui serbatoi cellulari del virus.
Diagnosi virologica: Studi volti alla validazione e “messa a punto” di test diagnostici. Analisi comparative di test diagnostici commerciali

Keywords

SARS- CoV-2
antiretroviral therapy hiv
HIV latency
drug resistance
antiretroviral therapy hiv

Gruppi di ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma